SLC2A9 and hypertensive disorder: The results of our meta-analysis combining six case–control studies (see Table 4) did not show a significant association between hypertension and the SLC2A9 variant tested (odds ratio 0.98, 95% CI 0.91 to 1.05, p > 0.6).